Charles K Marlowe

Title: The Innovative Contributions of Charles K. Marlowe

Introduction

Charles K. Marlowe is a notable inventor based in San Carlos, California. He has made significant contributions to the field of synthetic chemistry, particularly in the development of oligomers with potential therapeutic applications. His work has paved the way for new classes of peptide-like compounds that are synthetically accessible and biologically active.

Latest Patents

Marlowe holds a patent for the "Synthesis of N-substituted oligomers." This patent describes a solid-phase method for synthesizing N-substituted oligomers, such as poly(N-substituted glycines), which are of potential therapeutic interest. The method involves assembling each N-substituted glycine monomer from two 'sub-monomers' directly on a solid support. The process consists of two main steps: acylation of a secondary amine and the introduction of the side-chain through nucleophilic displacement. This innovative approach allows for the efficient synthesis of a wide variety of oligomeric NSGs, making them attractive candidates for generating diverse peptidomimetic libraries.

Career Highlights

Charles K. Marlowe has been associated with Chiron Corporation, where he has contributed to advancements in synthetic methodologies. His work has led to the development of combinatorial libraries of cyclic compounds, which include a diverse range of product compounds generated by the sequential addition of substituted submonomers. These libraries are significant for their potential to include biologically active compounds, which can be screened for various applications.

Collaborations

Marlowe has collaborated with notable colleagues such as Yazhong Pei and Simon C. Ng. Their combined expertise has further enhanced the research and development efforts within their field.

Conclusion

Charles K. Marlowe's innovative work in the synthesis of N-substituted oligomers has made a lasting impact on the field of synthetic chemistry. His contributions continue to influence the development of new therapeutic compounds and methodologies.